We investigated the association between schizophrenia and the allelic polymorphism in the apolipoprotein E (Apo E) gene in 51 schizophrenic patients and 35 controls. The Apo E4 allele was equally represented in the schizophrenic group (16%) and the control group (20%) suggesting no association betwe
Apolipoprotein E in schizophrenia: A French association study and meta-analysis
✍ Scribed by Franck Schürhoff; Marie-Odile Krebs; Andrei Szöke; Jean-Yves Loze; Céline Goldberger; Valérie Quignon; Jean Tignol; Frédéric Rouillon; Jean-Louis Laplanche; Marion Leboyer
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 79 KB
- Volume
- 119B
- Category
- Article
- ISSN
- 1552-4841
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The involvement of dopamine in the etiology of schizophrenia is suggested by a number of neurobiological and pharmacological data, the dopamine D3 receptor (DRD3) being selectively expressed in brain regions which may be specifically involved in the risk for schizophrenia. The gene coding for DRD3 h
A polymorphism caused by a G-to-A substitution in the promoter area (-75 bp) of the apolipoprotein AI (apo A-I) bene is common in the general population. Several studies have investigated its association with apo A-I levels, but the results were conflicting. Here, we undertook meta-analyses to incre